Ontology highlight
ABSTRACT:
SUBMITTER: Wiersema AM
PROVIDER: S-EPMC8449992 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature

Trials 20210919 1
<h4>Background</h4>Heparin is used worldwide for 70 years during all non-cardiac arterial procedures (NCAP) to reduce thrombo-embolic complications (TEC). But heparin also increases blood loss causing possible harm for the patient. Heparin has an unpredictable effect in the individual patient. The activated clotting time (ACT) can measure the effect of heparin. Currently, this ACT is not measured during NCAP as the standard of care, contrary to during cardiac interventions, open and endovascular ...[more]